365 related articles for article (PubMed ID: 10945612)
1. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
2. The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells.
Probst OC; Puxbaum V; Svoboda B; Leksa V; Stockinger H; Mikula M; Mikulits W; Mach L
Int J Cancer; 2009 Jun; 124(11):2559-67. PubMed ID: 19195023
[TBL] [Abstract][Full Text] [Related]
3. The 46-kDa mannose 6-phosphate receptor does not depend on endosomal acidification for delivery of hydrolases to lysosomes.
Probst OC; Ton P; Svoboda B; Gannon A; Schuhmann W; Wieser J; Pohlmann R; Mach L
J Cell Sci; 2006 Dec; 119(Pt 23):4935-43. PubMed ID: 17105763
[TBL] [Abstract][Full Text] [Related]
4. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells.
Probst OC; Karayel E; Schida N; Nimmerfall E; Hehenberger E; Puxbaum V; Mach L
Biochem J; 2013 Apr; 451(1):91-9. PubMed ID: 23347038
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
[TBL] [Abstract][Full Text] [Related]
7. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
Achkar C; Gong QM; Frankfater A; Bajkowski AS
J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of intracellular sorting and processing of lysosomal cathepsins H and L at reduced temperature in primary cultures of rat hepatocytes.
Nishimura Y; Kawabata T; Yano S; Kato K
Arch Biochem Biophys; 1990 Dec; 283(2):458-63. PubMed ID: 2275557
[TBL] [Abstract][Full Text] [Related]
9. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
Cuvier C; Jang A; Hill RP
Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
[TBL] [Abstract][Full Text] [Related]
10. Protein determinants impair recognition of procathepsin L phosphorylated oligosaccharides by the cation-independent mannose 6-phosphate receptor.
Lazzarino D; Gabel CA
J Biol Chem; 1990 Jul; 265(20):11864-71. PubMed ID: 2164020
[TBL] [Abstract][Full Text] [Related]
11. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.
Coulibaly S; Schwihla H; Abrahamson M; Albini A; Cerni C; Clark JL; Ng KM; Katunuma N; Schlappack O; Glössl J; Mach L
Int J Cancer; 1999 Nov; 83(4):526-31. PubMed ID: 10508490
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal cysteine protease, cathepsin B, is targeted to lysosomes by the mannose 6-phosphate-independent pathway in rat hepatocytes: site-specific phosphorylation in oligosaccharides of the proregion.
Tanaka Y; Tanaka R; Kawabata T; Noguchi Y; Himeno M
J Biochem; 2000 Jul; 128(1):39-48. PubMed ID: 10876156
[TBL] [Abstract][Full Text] [Related]
13. M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues.
Puxbaum V; Nimmerfall E; Bäuerl C; Taub N; Blaas PM; Wieser J; Mikula M; Mikulits W; Ng KM; Yeoh GC; Mach L
J Hepatol; 2012 Aug; 57(2):337-43. PubMed ID: 22521359
[TBL] [Abstract][Full Text] [Related]
14. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line.
De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C
Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605
[TBL] [Abstract][Full Text] [Related]
15. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
[TBL] [Abstract][Full Text] [Related]
16. Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the localization of cathepsin B and cathepsin L in human lung tumor cells.
Ulbricht B; Henny H; Horstmann H; Spring H; Faigle W; Spiess E
Eur J Cell Biol; 1997 Nov; 74(3):294-301. PubMed ID: 9402478
[TBL] [Abstract][Full Text] [Related]
17. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
[TBL] [Abstract][Full Text] [Related]
18. Analysis of where and which types of proteinases participate in lysosomal proteinase processing using bafilomycin A1 and Helicobacter pylori Vac A toxin.
Ishidoh K; Takeda-Ezaki M; Watanabe S; Sato N; Aihara M; Imagawa K; Kikuchi M; Kominami E
J Biochem; 1999 Apr; 125(4):770-9. PubMed ID: 10101291
[TBL] [Abstract][Full Text] [Related]
19. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
20. Mannose 6-phosphorylated proteins are required for tumor necrosis factor-induced apoptosis: defective response in I-cell disease fibroblasts.
Tardy C; Autefage H; Garcia V; Levade T; Andrieu-Abadie N
J Biol Chem; 2004 Dec; 279(51):52914-23. PubMed ID: 15452110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
